During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

With the number of FDA approved AI-enabled applications nearing 1,000, it’s clear the healthcare industry is ready to embrace the evolving technology.

The system combines findings from SPECT myocardial perfusion imaging with lifestyle and clinical factors to predict risk of major cardiovascular events.

And it can spot positioning errors in less than two seconds, new research suggests.

AI has shown great promise for improving early detection of breast cancer, but many algorithms are hindered by a lack of training on diverse datasets. 

The scanner is equipped with features aimed at addressing some of the biggest pain points of both radiologists and technologists.

American football isn’t the only contact sport that has medical experts concerned with the brain health of athletes. New evidence suggests certain soccer players may be at heightened risk of long-term brain abnormalities, too. 

Curtis P. Langlotz, MD, PhD, a noted physician and Stanford professor, spoke Sunday during the opening session of the society's 110th Scientific Assembly and Annual Meeting. 

RadNet Inc. presented new research at RSNA 2024, showing that women who paid $40 for an AI add-on experienced a 21% higher breast cancer detection rate. 

The findings are from a 10-year study of Vanderbilt University Medical Center's energy consumption, recently published in RSNA's Radiology. 

Tokyo-based Nihon Medi-Physics' portfolio includes nuclear imaging agents delivered across oncology, neurology and cardiology. 

Higher levels of visceral fat were linked to increased amyloid, according to new research being presented this week at RSNA 2024 in Chicago.